Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting
Clinical trial NCT05048589 · COMPLETED
Trial details
- NCT number
- NCT05048589
- Sponsor
- Tor Biering-Sørensen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-05-31
- Enrollment
- 12551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.